Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial
about
Aspirin intake and survival after breast cancerRegular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study.Anti-Inflammatory Agents for Cancer Therapy.Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women.Impact of acetylsalicylic Acid on the clinicopathological characteristics and prognosis of patients with invasive breast cancer.Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis.The role of aspirin in women's healthNon-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype.Potential contribution of aspirin to cancer control programmes.Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study.COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirinUse of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidenceProstaglandin E2 EP receptors as therapeutic targets in breast cancer.No effect of aspirin on mammographic density in a randomized controlled clinical trialAspirin-induced Bcl-2 translocation and its phosphorylation in the nucleus trigger apoptosis in breast cancer cellsRegular aspirin use and breast cancer risk in US Black women.Aspirin use is associated with lower mammographic density in a large screening cohort.Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs.
P2860
Q24604280-6E4AFCE4-266C-4153-B70B-955EA0A698AFQ33619700-6C76C60A-4599-4723-BE57-1A7D5EEA65E1Q33744129-79478268-FFC2-44BB-8A51-DB96C451A80CQ34034263-600C9ACE-B213-4CDA-A59E-B0F74B2DE32FQ34403601-43B1AB82-34D8-4806-872F-EEE39539D74AQ34458235-608F9E82-8E6B-4D7B-A7F9-C01D25C0B5E5Q35119642-342C088F-4080-4569-BC30-1BC10142ABE2Q35227086-398CD230-7F75-488B-9C9F-DE163B4A87ECQ35602238-0C4408ED-39AA-4B8B-B831-B5FDE1D63FFFQ35711979-6BD75AB7-F787-4269-BA46-FEF98DA5C3C1Q35797114-9096BE4F-8E03-445F-A4BE-56C67E50B92CQ36267669-034D37B5-C8EB-42D0-9F53-09AD59ACE895Q36806255-E97733E7-0B12-4AEB-AB9C-2B90BC03012BQ37210539-DEAF9B67-95F7-4E93-BB29-D99EAD072506Q37258255-D04D08B9-1D1E-4AA8-9FF7-E9D2D095B7B7Q37324216-54484E94-CDE9-46AF-B309-35B41F18A0ADQ39119109-FB12BACC-1533-4EA1-AC2F-65435AD0A542Q43061636-79A96BD6-DDE3-45C5-A834-135D799D3948
P2860
Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Low-dose aspirin and breast ca ...... istics from a randomised trial
@ast
Low-dose aspirin and breast ca ...... istics from a randomised trial
@en
type
label
Low-dose aspirin and breast ca ...... istics from a randomised trial
@ast
Low-dose aspirin and breast ca ...... istics from a randomised trial
@en
prefLabel
Low-dose aspirin and breast ca ...... istics from a randomised trial
@ast
Low-dose aspirin and breast ca ...... istics from a randomised trial
@en
P2093
P2860
P356
P1476
Low-dose aspirin and breast ca ...... istics from a randomised trial
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604240
P407
P577
2008-02-12T00:00:00Z